Maravai LifeSciences Announces September 2022 Investor Conference Schedule
Maravai LifeSciences (NASDAQ: MRVI) will participate in two upcoming investor conferences in September 2022. CEO Carl Hull will engage in a fireside chat at the Morgan Stanley Global Healthcare Conference on September 12 at 9:20 a.m. ET, followed by a presentation at the Baird Global Healthcare Conference on September 13 at 9:05 a.m. ET. Live webcasts of these events will be available on Maravai's Investor Relations website, with archived versions accessible post-event. Maravai specializes in providing life science reagents and services for drug development, diagnostics, and research.
- Participation in two high-profile investor conferences enhances visibility with investors.
- Live webcasts of the events promote transparency and shareholder engagement.
- None.
SAN DIEGO, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conferences during the month of September.
On September 12th, 2022, at 9:20 a.m. ET, Carl Hull, Chief Executive Officer, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference being held in New York City, New York.
On September 13th, 2022, at 9:05 a.m. ET, Mr. Hull will present at the Baird Global Healthcare Conference being held in New York City, New York.
A live webcast of the presentations will be available to all interested parties on the Maravai LifeSciences Investor Relations website, under Events and Presentations. An archived version of the webcasts will also be available on the Maravai website following the completion of each event.
About Maravai
Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologic safety testing to many of the world's leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies. For more information about Maravai LifeSciences, visit www.maravai.com.
FAQ
When is Maravai participating in investor conferences in September 2022?
Who will represent Maravai at the investor conferences?
Where can I watch the Maravai investor conference presentations?
What is the stock symbol for Maravai LifeSciences?
